Manulife (Manufacturers Life Insurance)’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Buy |
182,590
+45,106
| +33% | +$228K | ﹤0.01% | 1856 |
|
|
2025
Q1 | $727K | Buy |
137,484
+12,770
| +10% | +$67.6K | ﹤0.01% | 1955 |
|
|
2024
Q4 | $843K | Buy |
124,714
+60
| +0% | +$406 | ﹤0.01% | 1983 |
|
|
2024
Q3 | $821K | Buy |
124,654
+13,041
| +12% | +$85.9K | ﹤0.01% | 2021 |
|
|
2024
Q2 | $837K | Buy |
111,613
+27,440
| +33% | +$206K | ﹤0.01% | 1944 |
|
|
2024
Q1 | $839K | Buy |
84,173
+12,002
| +17% | +$120K | ﹤0.01% | 1946 |
|
|
2023
Q4 | $712K | Sell |
72,171
-2,556
| -3% | -$25.2K | ﹤0.01% | 2002 |
|
|
2023
Q3 | $572K | Buy |
74,727
+17,996
| +32% | +$138K | ﹤0.01% | 2067 |
|
|
2023
Q2 | $424K | Buy |
56,731
+560
| +1% | +$4.18K | ﹤0.01% | 2140 |
|
|
2023
Q1 | $375K | Buy |
56,171
+393
| +0.7% | +$2.62K | ﹤0.01% | 2185 |
|
|
2022
Q4 | $430K | Buy |
55,778
+1,458
| +3% | +$11.2K | ﹤0.01% | 2084 |
|
|
2022
Q3 | $578K | Sell |
54,320
-1,074
| -2% | -$11.4K | ﹤0.01% | 1883 |
|
|
2022
Q2 | $451K | Sell |
55,394
-29,566
| -35% | -$241K | ﹤0.01% | 2121 |
|
|
2022
Q1 | $607K | Buy |
84,960
+26,943
| +46% | +$193K | ﹤0.01% | 2072 |
|
|
2021
Q4 | $1K | Buy |
58,017
+41,107
| +243% | +$710 | ﹤0.01% | 1822 |
|
|
2021
Q3 | $389K | Buy |
16,910
+2,670
| +19% | +$61.4K | ﹤0.01% | 2472 |
|
|
2021
Q2 | $520K | Buy |
+14,240
| New | +$520K | ﹤0.01% | 2400 |
|